A randomized, open-label, single-dose, two-period, two-way crossover pharmacokinetic study of silymarin capsules (140mg) in healthy subjects under fasting conditions

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: cf31abc4c38a0bf4ac385fe77600c9fa61cca2d6
First added on: Apr 22, 2026